Patient‐reported outcomes from SYNERGY, a randomized, double‐blind, multicenter study evaluating combinations of mirabegron and solifenacin compared with monotherapy and placebo in OAB patients

Publisher: John Wiley & Sons Inc

E-ISSN: 1520-6777|37|1|394-406

ISSN: 0733-2467

Source: NEUROUROLOGY AND URODYNAMICS, Vol.37, Iss.1, 2018-01, pp. : 394-406

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content